Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
69.20 EUR | -2.60% |
|
+7.87% | -1.20% |
Jul. 09 | Wacker Chemie expands bio research in Munich | DP |
Jul. 07 | DZ Bank downgrades Wacker Chemie to 'Hold' – fair value €70 | DP |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.39 | 8.58 | 10.3 | 2.1 | 1.68 | |||||
Return on Total Capital | 5.03 | 16.96 | 16.25 | 3.03 | 2.38 | |||||
Return On Equity % | 10.87 | 34.55 | 31.52 | 6.81 | 5.54 | |||||
Return on Common Equity | 10.53 | 34.75 | 31.74 | 6.76 | 5.3 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 18.54 | 26.94 | 26.32 | 16.92 | 17.24 | |||||
SG&A Margin | 9.77 | 7.66 | 6.67 | 8.44 | 10.03 | |||||
EBITDA Margin % | 13.39 | 22.67 | 22.03 | 10.72 | 11.83 | |||||
EBITA Margin % | 5.7 | 16.81 | 17.79 | 5.09 | 4.67 | |||||
EBIT Margin % | 5.48 | 16.69 | 17.6 | 4.79 | 4.29 | |||||
Income From Continuing Operations Margin % | 4.31 | 13.34 | 15.61 | 5.11 | 4.56 | |||||
Net Income Margin % | 4.03 | 13 | 15.24 | 4.9 | 4.21 | |||||
Net Avail. For Common Margin % | 4.03 | 13 | 15.24 | 4.9 | 4.21 | |||||
Normalized Net Income Margin | 3.31 | 10.55 | 11.74 | 3.36 | 2.51 | |||||
Levered Free Cash Flow Margin | 1.82 | 13.19 | 1.8 | 2.7 | -6.95 | |||||
Unlevered Free Cash Flow Margin | 2.12 | 13.42 | 2.02 | 3.09 | -6.45 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.7 | 0.82 | 0.94 | 0.7 | 0.63 | |||||
Fixed Assets Turnover | 1.78 | 2.43 | 2.95 | 2.06 | 1.67 | |||||
Receivables Turnover (Average Receivables) | 7.46 | 8.55 | 9.43 | 7.51 | 7.37 | |||||
Inventory Turnover (Average Inventory) | 4.11 | 4.41 | 4.27 | 3.43 | 2.92 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 4.33 | 2.25 | 2.42 | 2.21 | 2.66 | |||||
Quick Ratio | 2.5 | 1.54 | 1.51 | 1.33 | 1.42 | |||||
Operating Cash Flow to Current Liabilities | 1.06 | 0.62 | 0.58 | 0.53 | 0.2 | |||||
Days Sales Outstanding (Average Receivables) | 49.08 | 42.68 | 38.7 | 48.6 | 49.68 | |||||
Days Outstanding Inventory (Average Inventory) | 89.02 | 82.76 | 85.47 | 106.53 | 125.4 | |||||
Average Days Payable Outstanding | 38.31 | 44.79 | 46.06 | 62.99 | 62.32 | |||||
Cash Conversion Cycle (Average Days) | 99.79 | 80.65 | 78.11 | 92.14 | 112.76 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 83.08 | 46.34 | 30.75 | 32.87 | 40.25 | |||||
Total Debt / Total Capital | 45.38 | 31.67 | 23.52 | 24.74 | 28.7 | |||||
LT Debt/Equity | 78.18 | 34.32 | 21.58 | 23.76 | 35.67 | |||||
Long-Term Debt / Total Capital | 42.7 | 23.45 | 16.5 | 17.88 | 25.44 | |||||
Total Liabilities / Total Assets | 75.66 | 61.88 | 46.49 | 48.28 | 48.6 | |||||
EBIT / Interest Expense | 11.69 | 46.04 | 50.53 | 7.61 | 5.38 | |||||
EBITDA / Interest Expense | 29.98 | 63.97 | 64.59 | 18 | 15.75 | |||||
(EBITDA - Capex) / Interest Expense | 19.69 | 49.69 | 44.97 | 2.13 | 1.46 | |||||
Total Debt / EBITDA | 2.13 | 1 | 0.84 | 2.08 | 2.71 | |||||
Net Debt / EBITDA | 0.1 | -0.16 | -0.12 | 0.2 | 1.02 | |||||
Total Debt / (EBITDA - Capex) | 3.25 | 1.29 | 1.2 | 17.53 | 29.23 | |||||
Net Debt / (EBITDA - Capex) | 0.16 | -0.2 | -0.18 | 1.68 | 10.98 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -4.78 | 32.29 | 32.25 | -22.01 | -10.63 | |||||
Gross Profit, 1 Yr. Growth % | 25.94 | 92.26 | 29.2 | -49.88 | -8.89 | |||||
EBITDA, 1 Yr. Growth % | 15.35 | 124.07 | 28.48 | -62.04 | -1.38 | |||||
EBITA, 1 Yr. Growth % | 620.49 | 290.31 | 39.96 | -77.67 | -18.07 | |||||
EBIT, 1 Yr. Growth % | 966.8 | 302.92 | 39.5 | -78.77 | -19.98 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -132.13 | 309.19 | 54.82 | -74.46 | -20.35 | |||||
Net Income, 1 Yr. Growth % | -129.44 | 326.48 | 55.04 | -74.93 | -23.15 | |||||
Normalized Net Income, 1 Yr. Growth % | 894.16 | 321.65 | 47.11 | -77.64 | -33.34 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -129.44 | 326.48 | 55.04 | -74.93 | -23.15 | |||||
Accounts Receivable, 1 Yr. Growth % | -0.71 | 31.55 | 11.08 | -13.93 | -3.04 | |||||
Inventory, 1 Yr. Growth % | -10.24 | 33.83 | 40.68 | -12.48 | 23.9 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -9.4 | 4.06 | 13.64 | 10.12 | 10.29 | |||||
Total Assets, 1 Yr. Growth % | 7.08 | 17.03 | 15.58 | -5.82 | 6.27 | |||||
Tangible Book Value, 1 Yr. Growth % | -17.21 | 85.31 | 56.46 | -11.34 | 6.24 | |||||
Common Equity, 1 Yr. Growth % | -17.37 | 85.73 | 61.13 | -9.19 | 5.71 | |||||
Cash From Operations, 1 Yr. Growth % | 44.41 | 21.83 | 5.74 | -16.81 | -66.85 | |||||
Capital Expenditures, 1 Yr. Growth % | -45.43 | 41.85 | 74.67 | 13.97 | 1.88 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -286.1 | 28.78 | -81.94 | 16.73 | -330.2 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -407.04 | 28.22 | -80.1 | 19.34 | -286.49 | |||||
Dividend Per Share, 1 Yr. Growth % | 300 | 300 | 50 | -75 | -16.67 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -2.92 | 12.24 | 32.27 | 1.56 | -16.51 | |||||
Gross Profit, 2 Yr. CAGR % | -0.27 | 55.61 | 57.61 | -19.53 | -32.43 | |||||
EBITDA, 2 Yr. CAGR % | -9.96 | 60.77 | 69.67 | -30.16 | -38.82 | |||||
EBITA, 2 Yr. CAGR % | 3.86 | 430.3 | 133.73 | -44.1 | -57.23 | |||||
EBIT, 2 Yr. CAGR % | 4.73 | 555.62 | 137.08 | -45.58 | -58.78 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -11.81 | 14.66 | 151.7 | -37.12 | -54.9 | |||||
Net Income, 2 Yr. CAGR % | -12.32 | 12.06 | 157.14 | -37.66 | -56.11 | |||||
Normalized Net Income, 2 Yr. CAGR % | -9.7 | 547.44 | 149.05 | -42.65 | -61.39 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -12.32 | 12.06 | 157.14 | -37.66 | -56.11 | |||||
Accounts Receivable, 2 Yr. CAGR % | -4.11 | 14.28 | 20.88 | -2.22 | -8.65 | |||||
Inventory, 2 Yr. CAGR % | -6.72 | 9.6 | 37.21 | 10.96 | 4.13 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -15.72 | -2.9 | 8.74 | 11.87 | 10.21 | |||||
Total Assets, 2 Yr. CAGR % | -1.19 | 11.94 | 16.3 | 4.33 | 0.05 | |||||
Tangible Book Value, 2 Yr. CAGR % | -27.47 | 23.86 | 70.27 | 17.78 | -2.95 | |||||
Common Equity, 2 Yr. CAGR % | -27.44 | 23.88 | 73 | 20.96 | -2.02 | |||||
Cash From Operations, 2 Yr. CAGR % | 30.94 | 32.64 | 13.5 | -6.21 | -47.48 | |||||
Capital Expenditures, 2 Yr. CAGR % | -25.56 | -12.02 | 57.41 | 41.09 | 7.75 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -12.46 | 322.12 | -51.77 | -54.08 | 63.93 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -11.51 | 407.55 | -49.48 | -51.27 | 49.18 | |||||
Dividend Per Share, 2 Yr. CAGR % | -10.56 | 300 | 144.95 | -38.76 | -54.36 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -1.6 | 7.63 | 18.55 | 10.91 | -2.68 | |||||
Gross Profit, 3 Yr. CAGR % | -3.04 | 24.12 | 46.25 | 7.58 | -16.13 | |||||
EBITDA, 3 Yr. CAGR % | -12.86 | 22.01 | 49.19 | 3 | -21.65 | |||||
EBITA, 3 Yr. CAGR % | -10.44 | 61.47 | 240.16 | 6.84 | -36.5 | |||||
EBIT, 3 Yr. CAGR % | -10.53 | 64.1 | 291.41 | 6.07 | -38.12 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -6.83 | 47.09 | 26.73 | 17.4 | -31.96 | |||||
Net Income, 3 Yr. CAGR % | -39.79 | 48.56 | 24.86 | 18.35 | -33.16 | |||||
Normalized Net Income, 3 Yr. CAGR % | -6.9 | 50.93 | 295.08 | 11.52 | -39.7 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -6.57 | 48.56 | 24.86 | 18.35 | -33.16 | |||||
Accounts Receivable, 3 Yr. CAGR % | -1.48 | 6.55 | 13.21 | 7.94 | -2.49 | |||||
Inventory, 3 Yr. CAGR % | 3.92 | 5.21 | 19.11 | 18.11 | 15.12 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -10.57 | -9.59 | 2.33 | 9.2 | 11.34 | |||||
Total Assets, 3 Yr. CAGR % | 0.56 | 4.55 | 13.14 | 8.4 | 4.98 | |||||
Tangible Book Value, 3 Yr. CAGR % | -19.52 | -0.84 | 33.89 | 36.98 | 13.8 | |||||
Common Equity, 3 Yr. CAGR % | -19.53 | -0.75 | 35.23 | 39.55 | 15.65 | |||||
Cash From Operations, 3 Yr. CAGR % | 9.96 | 27.83 | 22.99 | 2.33 | -33.69 | |||||
Capital Expenditures, 3 Yr. CAGR % | -11.63 | -7.71 | 10.57 | 41.34 | 26.58 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -42.58 | 94.32 | 47.64 | -35.25 | -21.41 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -40.84 | 87.29 | 72.43 | -32.72 | -23.77 | |||||
Dividend Per Share, 3 Yr. CAGR % | -7.17 | 47.36 | 188.45 | 14.47 | -32.14 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -2.39 | 6.02 | 10.76 | 5.16 | 3.03 | |||||
Gross Profit, 5 Yr. CAGR % | -5.08 | 15.24 | 17.75 | 4.36 | 7.39 | |||||
EBITDA, 5 Yr. CAGR % | -7.61 | 9.86 | 13.75 | -2.39 | 4.45 | |||||
EBITA, 5 Yr. CAGR % | -5.65 | 30.69 | 31.45 | 5.64 | 48.41 | |||||
EBIT, 5 Yr. CAGR % | -6.38 | 31.94 | 32.12 | 5.53 | 59.08 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -3.5 | 35.97 | 38.65 | 4.7 | -16.17 | |||||
Net Income, 5 Yr. CAGR % | -5.17 | 35.11 | 7.62 | 4.97 | -17.81 | |||||
Normalized Net Income, 5 Yr. CAGR % | -1.96 | 40.44 | 38 | 2.49 | 55.84 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -5.17 | 36.87 | 40.07 | 4.97 | -17.81 | |||||
Accounts Receivable, 5 Yr. CAGR % | -1.59 | 1.24 | 6.92 | 2.95 | 3.9 | |||||
Inventory, 5 Yr. CAGR % | 2.29 | 6.82 | 16.14 | 7.47 | 12.88 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -12.2 | -10.72 | -3.29 | -1.55 | 5.41 | |||||
Total Assets, 5 Yr. CAGR % | -0.88 | 1.74 | 6.58 | 4.46 | 7.71 | |||||
Tangible Book Value, 5 Yr. CAGR % | -8.75 | 5 | 8.61 | 6.22 | 17.72 | |||||
Common Equity, 5 Yr. CAGR % | -8.75 | 4.87 | 9.29 | 7.43 | 18.88 | |||||
Cash From Operations, 5 Yr. CAGR % | 7.2 | 7.64 | 11.36 | 12.94 | -12.49 | |||||
Capital Expenditures, 5 Yr. CAGR % | -22.7 | -5.11 | 11.33 | 9.37 | 9.44 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -8.29 | 40.63 | -20.02 | 9.12 | 53.95 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -1.66 | 36.26 | -19.14 | 9.31 | 62.73 | |||||
Dividend Per Share, 5 Yr. CAGR % | 0 | 31.95 | 36.85 | 3.71 | 37.97 |
- Stock Market
- Equities
- WCH Stock
- Financials Wacker Chemie AG
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions